Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease ... Alzheimer's Treatment One Step ...

The treatment is not a permanent fix for Alzheimer's dementia, Jing said, because the disease will eventually ... It's important for them to know there are options out there." ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Some research shows it may have benefits for people with Alzheimer’s disease, but current evidence is mixed. Melatonin is a hormone produced by a small gland in your brain called the pineal gland.

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ...

Summary: Researchers have linked chronic intestinal infections caused by cytomegalovirus (HCMV) to a unique subtype of Alzheimer’s disease. The virus may travel from the gut to ... test to identify ...